Follow-up for Urinary tract infection, site not specified in the context of a patient with chronic illness and poor overall outcomes.
65 y/o male was seen at the bedside with a medical history of Respiratory Disorder, Chronic obstructive pulmonary disease, unspecified Dementia, Essential (primary) hypertension, and Human immunodeficiency virus [HIV] disease seen for a follow-up for Urinary tract infection, site not specified. The patient denies SOB, chest pain, painful urination, and frequency. The patient was seen and evaluated today and was in no acute distress. The patient is awake and alert and in stable condition. The patient was seen at the bedside to provide medically necessary care due to extensive comorbidities requiring a complex interdisciplinary approach.
No known allergies
Levofloxacin tablet; 500 mg; amt: 500 mg; oral Begin; 03/12/2025 -03/19/2025
End: 03/19/2025
N39.0 Urinary tract infection, site not specified
Levofloxacin tablet; 500 mg; amt: 500 mg; oral Begin; 03/12/2025 -03/19/2025
End: 03/19/2025
It is essential to complete the full course of prescribed antibiotics, even if symptoms improve early, to fully clear the infection and prevent resistance. Staying well-hydrated by drinking plenty of water helps flush bacteria from the urinary tract. The patient should avoid alcohol, caffeine, and acidic foods that may irritate the bladder. Proper hygiene, including urinating after sexual activity, can help prevent reinfection. Monitoring for symptoms such as fever, worsening pain, blood in the urine, or difficulty urinating is important, and medical attention Should be sought if these occur.